Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Doyen

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Oncogenesis|July 4, 2017
Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinomaM Lupu-Plesu, A Claren, S Martial, et al.
Lung Cancer (Amsterdam, Netherlands)|May 21, 2021
Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancerL Duvergé, P-Y Bondiau, L Claude, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 13, 2024
'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility studyD Mitrea, N Barbet, T Pacé-Loscos, et al.
Cell Death & Disease|March 16, 2013
MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell linesS Grosso, J Doyen, S K Parks, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 10, 2020
Stereotactic Pelvic Reirradiation for Locoregional Cancer RelapseR Kinj, J Doyen, J M Hannoun-Lévi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 4, 2022
Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancerS Sumodhee, L Guo, L Bouhlel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 11, 2020
[Role of immunotherapy in locally advanced non-small cell lung cancer]A Levy, J Doyen, A Botticella, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 4, 2019
[Proton therapy in France in 2019]R Dendale, J Thariat, J Doyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2008
Prognostic factors in 1,038 women with metastatic breast cancerR Largillier, J-M Ferrero, J Doyen, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 29, 2021
Fractionated Stereotactic Radiation Therapy for Pituitary Adenomas: An alternative escalating protocol of hypofractionated stereotactic radiotherapy delivering 35Gy in 5 fractionsS Sumodhee, V Atallah, R Kinj, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Oncogenesis|July 4, 2017
Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinomaM Lupu-Plesu, A Claren, S Martial, et al.
Lung Cancer (Amsterdam, Netherlands)|May 21, 2021
Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancerL Duvergé, P-Y Bondiau, L Claude, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 13, 2024
'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility studyD Mitrea, N Barbet, T Pacé-Loscos, et al.
Cell Death & Disease|March 16, 2013
MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell linesS Grosso, J Doyen, S K Parks, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 10, 2020
Stereotactic Pelvic Reirradiation for Locoregional Cancer RelapseR Kinj, J Doyen, J M Hannoun-Lévi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 4, 2022
Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancerS Sumodhee, L Guo, L Bouhlel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 11, 2020
[Role of immunotherapy in locally advanced non-small cell lung cancer]A Levy, J Doyen, A Botticella, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 4, 2019
[Proton therapy in France in 2019]R Dendale, J Thariat, J Doyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2008
Prognostic factors in 1,038 women with metastatic breast cancerR Largillier, J-M Ferrero, J Doyen, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 29, 2021
Fractionated Stereotactic Radiation Therapy for Pituitary Adenomas: An alternative escalating protocol of hypofractionated stereotactic radiotherapy delivering 35Gy in 5 fractionsS Sumodhee, V Atallah, R Kinj, et al.
Pageof 7